Everolimus in Treating Patients With Stage IV Melanoma

Clinical trial NCT00098553 · COMPLETED

Trial details

NCT number: NCT00098553
Sponsor: Alliance for Clinical Trials in Oncology
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2005-04-01
Primary completion: 2007-07-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.